[HTML][HTML] Efficacy and safety of afatinib for EGFR-mutant non-small cell lung cancer, compared with gefitinib or erlotinib
Y Kim, SH Lee, JS Ahn, MJ Ahn, K Park… - Cancer Research and …, 2019 - ncbi.nlm.nih.gov
Purpose We tried to evaluate whether there are any specific features in treatment outcomes
of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small …
of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small …
[PDF][PDF] Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Y Kim, SH Lee, JS Ahn, MJ Ahn, K Park… - Cancer Res …, 2018 - pdfs.semanticscholar.org
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared
with Gefitinib or Erlotinib Page 1 Cancer Res Treat. 2018 Jun 13 [Epub ahead of print] …
with Gefitinib or Erlotinib Page 1 Cancer Res Treat. 2018 Jun 13 [Epub ahead of print] …
Efficacy and safety of afatinib for EGFR-mutant non-small cell lung cancer, compared with gefitinib or erlotinib
Y Kim, SH Lee, JS Ahn, MJ Ahn… - Cancer Research …, 2019 - mdanderson.elsevierpure.com
Purpose We tried to evaluate whether there are any specific features in treatment outcomes
of first-line afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non …
of first-line afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non …
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Y KIM, SH LEE, JS AHN, MJ AHN… - Cancer Research …, 2019 - pesquisa.bvsalud.org
PURPOSE: We tried to evaluate whether there are any specific features in treatment
outcomes of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant …
outcomes of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant …
[PDF][PDF] Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Y Kim, SH Lee, JS Ahn, MJ Ahn, K Park… - Cancer Res …, 2019 - e-sciencecentral.org
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with
Gefitinib or Erlotinib Page 1 l https://www.e-crt.org l 502 Copyright ⓒ 2019 by the Korean …
Gefitinib or Erlotinib Page 1 l https://www.e-crt.org l 502 Copyright ⓒ 2019 by the Korean …
[HTML][HTML] Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Y Kim, SH Lee, JS Ahn, MJ Ahn, K Park… - Cancer Research and …, 2018 - e-crt.org
Purpose We tried to evaluate whether there are any specific features in treatment outcomes
of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small …
of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small …
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Y Kim, SH Lee, JS Ahn, MJ Ahn… - CANCER …, 2019 - scholarworks.bwise.kr
Purpose We tried to evaluate whether there are any specific features in treatment outcomes
of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small …
of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small …
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib.
Y Kim, SH Lee, JS Ahn, MJ Ahn, K Park… - Cancer Research and …, 2018 - europepmc.org
Purpose We tried to evaluate whether there are any specific features in treatment outcomes
of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small …
of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small …
[引用][C] Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
Y Kim, SH Lee, JS Ahn, MJ Ahn, K Park… - Cancer Research and …, 2019 - cir.nii.ac.jp
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with
Gefitinib or Erlotinib | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
Gefitinib or Erlotinib | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
김유진， 이세훈， 안진석， 안명주， 박근칠… - Cancer Research and …, 2019 - dbpia.co.kr
Purpose We tried to evaluate whether there are any specific features in treatment outcomes
of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small …
of firstline afatinib in patients with epidermal growth factor receptor (EGFR)-mutant non-small …